Search results for "Inde"

showing 10 items of 7365 documents

Salt-regulating hormones in young normotensive obese subjects. Effects of saline load.

1994

To investigate whether the response of salt-regulating hormones to volume expansion is impaired in obese subjects, we assessed the effects of saline load (0.25 mL/kg.min.120 min) in 9 young, healthy, normotensive obese subjects (body mass index, > 30 kg/m2) and in 10 lean control subjects (body mass index, < 25 kg/m2) matched for age, gender, height, and mean blood pressure. Hematocrit, plasma renin activity (PRA), plasma aldosterone (PA), atrial natriuretic factor (ANF), and urinary sodium excretion (UNaV) were evaluated. Saline load increased ANF levels significantly (P < .001) in lean subjects at both 60 and 120 minutes, whereas they decreased in obese subjects. Such decreases b…

AdultBlood GlucoseMalemedicine.medical_specialtySettore MED/09 - Medicina Internarenin-angiotensin system obesity atrial natriuretic factor hypertension sodium dependent.Systolemedicine.medical_treatmentBlood PressureHematocritPlasma renin activityBody Mass Indexchemistry.chemical_compoundAtrial natriuretic peptideDiastoleHeart RateReference ValuesInternal medicineBlood plasmaReninInternal MedicinemedicineHumansInsulinObesitySalineAldosteroneAldosteronemedicine.diagnostic_testbusiness.industrySodiumSettore MED/11 - Malattie Dell'Apparato CardiovascolareBlood pressureEndocrinologychemistryHematocritEchocardiographyCreatinineFemalebusinessBody mass indexAtrial Natriuretic FactorHypertension (Dallas, Tex. : 1979)
researchProduct

Glycaemic variability and inflammation in subjects with metabolic syndrome.

2008

Subjects who develop diabetes have an increased cardiovascular risk even before the appearance of diabetes. The aim of this study was to investigate the glycaemic variability measured by continuous glucose monitoring (CGM CV%) in nondiabetic subjects with metabolic syndrome (MS) and to explore if glycaemic variability was associated with circulating levels of interleukin-6 (IL-6), a proinflammatory cytokine, or with an anti-inflammatory factor like adiponectin. Three groups of obese subjects with (MS+: 6m, 8f; BMI 33.1 ± 1.4 mean ± SEM) or without metabolic syndrome (MS−: 2m, 4f; BMI 29.2 ± 2.2) and with MS associated with type 2 diabetes (MS/T2D: 3m, 5f; BMI 32.9 ± 1.4) were investigated. …

AdultBlood GlucoseMalemedicine.medical_specialtyWaistendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMonitoring AmbulatoryBlood sugarType 2 diabetesBody Mass IndexEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansObesityMetabolic SyndromeAdiponectinbusiness.industryInsulinReproducibility of Resultsnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseObesityEndocrinologyFemaleWaist CircumferenceMetabolic syndromeVariabilità glicemica flogosi sindrome metabolicabusiness
researchProduct

The effect of growth hormone ( GH ) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real‐life data from th…

2015

SummaryObjective To assess the effect of 4 years’ growth hormone (GH) replacement on glucose homeostasis and evaluate factors affecting glycosylated haemoglobin (HbA1c) in adults with growth hormone deficiency (GHD). Design NordiNet® International Outcome Study, a noninterventional study, monitors long-term effectiveness and safety of GH replacement [Norditropin® (somatropin), Novo Nordisk A/S] in real-life clinical practice. Patients Nondiabetic patients (n = 245) with adult-onset GHD (age ≥20 years at GH start), ≥4 years’ GH replacement and HbA1c values at baseline and 4 years were included in the analysis. Measurements Changes from baseline (∆) to 4 years in HbA1c, fasting plasma glucose…

AdultBlood GlucoseMalemedicine.medical_specialtyWaistendocrine system diseasesHormone Replacement TherapyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematologyGrowth hormone deficiencyImpaired glucose toleranceYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusDiabetes MellitusmedicineHomeostasisHumansGlucose homeostasisYoung adultAgedAged 80 and overGlycated Hemoglobinbusiness.industrynutritional and metabolic diseasesMiddle Agedmedicine.diseaseSomatropinTreatment OutcomeEndocrinologyGrowth HormoneFemalebusinessBody mass indexClinical Endocrinology
researchProduct

Classical cardiovascular risk factors according to fasting plasma glucose levels

2007

To compare the prevalence of classical cardiovascular risk factors (CVRF) and metabolic syndrome (MetS) in our population according to fasting plasma glucose levels (FPG).We have studied 344 subjects between 20-70 years of age, recruited in a Primary Care Clinic. Subjects were divided into four groups according to their fasting plasma glucose (FPG) values: normal plasma glucose (NG) when FPG5.6 mmol/L; FPG between 5.6 and 6.0 mmol/L (FPG1); FPG between 6.1-6.9 mmol/L (FPG2); and diabetes (DM) FPGor = 7 mmol/L or previous diagnosis of diabetes. Cardiovascular risk factors (hypertension, TC/HDL-C index and Apo B values), presence of the MetS and indirect measure of insulin resistance (HOMA) w…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesPopulationCardiovascular risk factorsComorbiditySeverity of Illness IndexRisk FactorsInternal medicinePrevalenceInternal MedicinemedicineHumanseducationPractical implicationsAgedMetabolic Syndromeeducation.field_of_studyPlasma glucosebusiness.industrynutritional and metabolic diseasesType 2 Diabetes MellitusFastingMiddle AgedImpaired fasting glucosemedicine.diseasePrimary care clinicCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesSpainFemaleMetabolic syndromebusinessEuropean Journal of Internal Medicine
researchProduct

Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension

2005

The objective was to assess the temporal impact of factors related to the development of microalbuminuria during the follow-up of young adult normoalbuminurics with high-normal blood pressure or at stage 1 of essential hypertension. Prospective follow-up was conducted on 245 normoalbuminuric hypertensive subjects (mean age 40.9 years; 134 men; blood pressure 139.7/88.6 mm Hg; body mass index 28.5 kg/m 2 ) never treated previously with antihypertensive drugs, with yearly urinary albumin excretion measurements, until the development of microalbuminuria. After enrollment, patients were placed on usual care including nonpharmacological treatment or with an antihypertensive drug regime to achie…

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.drug_classBlood PressureEssential hypertensionPrehypertensionRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaHumansProspective StudiesAntihypertensive drugAntihypertensive AgentsProportional Hazards ModelsProteinuriabusiness.industryFastingmedicine.diseaseEndocrinologyBlood pressureHypertensionMultivariate AnalysisDisease ProgressionAlbuminuriaCardiologyFemaleMicroalbuminuriamedicine.symptombusinessBody mass indexFollow-Up StudiesHypertension
researchProduct

Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.

2003

OBJECTIVE—To identify a reliable yet simple indirect method for detection of insulin resistance (IR). RESEARCH DESIGN AND METHODS—A total of 65 subjects (44 men and 21 women aged 30–60 years) were selected by a simple random sampling method. Inclusion criteria were voluntary participation from staff and hospital personnel, absence of abnormal glucose tolerance, and normal results of lipid profile and basic blood chemistry. A blood sample was taken after a 12-h overnight fast to determine plasma lipid, glucose, and insulin levels. An intravenous glucose tolerance test with administration of insulin after 20 min and extraction of multiple blood samples for glucose and insulin measurements and…

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentEndocrinology Diabetes and MetabolismCarbohydrate metabolismModels BiologicalInsulin resistanceReference ValuesInternal medicineDiabetes mellitusInternal MedicinemedicineHomeostasisHumansInsulinObesityAdvanced and Specialized NursingGlucose tolerance testSex Characteristicsmedicine.diagnostic_testbusiness.industryInsulinQuantitative insulin sensitivity check indexInsulin sensitivityFastingGlucose Tolerance Testmedicine.diseaseLipidsEndocrinologyClampGlucoseBlood chemistryFemaleMetabolic syndromeInsulin ResistanceLipid profilebusinessDiabetes care
researchProduct

In renal transplanted patients inflammation and oxidative stress are interrelated.

2006

Introduction: The inflammatory state plays a well-documented role to cause oxidative stress, especially in end-stage renal disease (ESRD) patients, wherein several cardiovascular risk factors are amplified by the coexistence of a microinflammatory state with increased oxidative stress. Methods: We measured serum concentrations of high sensitivity C-reactive protein (CRP), tumor necrosis factor α (TNFα), 8-iso-prostaglandin F2α (8-iso-PGF2α-in vivo oxidative stress marker) in 15 chronic renal failure (CRF) and 15 transplant patients versus 15 healthy controls. Exclusion criteria were: age 65 years as well as a diagnosis of diabetes or cardiovascular diseases. We evaluated systolic (SBP) and …

AdultBlood GlucoseMalemedicine.medical_specialtyrenal transplantation oxidative stress inflammationRenal functionInflammationBlood Pressuremedicine.disease_causeWhite PeopleBody Mass Indexchemistry.chemical_compoundDiabetes mellitusInternal medicinemedicineCadaverHumansInflammationTransplantationCreatinineAnalysis of Variancebusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationTissue DonorsOxidative StressBlood pressureEndocrinologyC-Reactive ProteinchemistryItalyKidney Failure ChronicSurgeryTumor necrosis factor alphamedicine.symptombusinessBody mass indexOxidative stressBiomarkersGlomerular Filtration Rate
researchProduct

Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk fa…

2013

Abstract STUDY QUESTION: What alters cardiovascular and metabolic risk factors with aging in women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Lipid parameters, mainly low-density lipoprotein (LDL) cholesterol, increase with aging, but not in women who attain ovulatory cycles. WHAT IS KNOWN ALREADY: Cardiovascular and metabolic parameters tend to increase with aging, but this has not been shown in a prospective longitudinal study in women with PCOS. Correlates of these changes have not been identified. STUDY DESIGN: A prospective cohort of 118 hyperandrogenic women with PCOS who were followed from the age of 20-25 years at 5 year intervals for 20 years. PARTICIPANTS/MATERIALS, SE…

AdultBlood GlucoseOvulationmedicine.medical_specialtyWaistSettore MED/09 - Medicina Internamedia_common.quotation_subjectmedicine.medical_treatmentBiologyBody Mass IndexSettore MED/13 - EndocrinologiaRisk FactorsInternal medicineTotal cholesterolPrevalencemedicineHumansInsulinLongitudinal StudiesGonadal Steroid HormonesOvulationmedia_commonMetabolic SyndromeCompeting interestsInsulinPolycystic ovary syndrome (PCOS)RehabilitationMetabolic riskAge Factorsnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseaseLipidsSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyReproductive MedicineCardiovascular DiseasesPCOS Cardiovascular risk aging hyperandrogenism ovarian function lipid alterationsFemalelipids (amino acids peptides and proteins)Waist CircumferenceMetabolic syndromePolycystic Ovary Syndrome
researchProduct

Ethnic differences in serum lipoproteins and their determinants in South African women.

2010

The objective of the study was to characterize ethnic differences in lipid levels and low-density lipoprotein (LDL) particle size and subclasses in black and white South African women and to explore the associations with insulin sensitivity (S(I)), body composition, and lifestyle factors. Fasting serum lipids and LDL size and subclasses, body composition (dual-energy x-ray absorptiometry), and S(I) (frequently sampled intravenous glucose tolerance test) were measured in normal-weight (body mass index25 kg/m(2)) black (n = 15) and white (n = 15), and obese (body mass index30 kg/m(2)) black (n = 13) and white (n = 13) women. Normal-weight and obese black women had lower triglycerides (0.59 +/…

AdultBlood Glucosemedicine.medical_specialtyEndocrinology Diabetes and MetabolismLipoproteinsBlood lipidsBlack PeopleMotor ActivityStatistics NonparametricBody Mass Indexchemistry.chemical_compoundSouth AfricaEndocrinologyHigh-density lipoproteinInternal medicineMedicineHumansInsulinObesityTriglyceridesBlack womenImmunoassayTriglyceridebusiness.industryCholesterolPatient SelectionEndocrinologychemistrySocioeconomic FactorsLow-density lipoproteinBody CompositionRegression Analysislipids (amino acids peptides and proteins)FemaleDietary ProteinsInsulin ResistancebusinessBody mass indexLipoproteinMetabolism: clinical and experimental
researchProduct

Endothelial dysfunction in PCOS. role of obesity and adipose hormones

2006

PURPOSE: Polycystic ovary syndrome (PCOS) is an extremely prevalent disorder in which elevated blood markers of cardiovascular risk and altered endothelial function have been found. This study was designed to determine if abnormal carotid intima-media thickness (IMT) and brachial flow-mediated dilation (FMD) in young women with PCOS may be explained by insulin resistance and elevated adipocytokines. METHODS: A prospective study in 50 young women with PCOS (age: 25.2 +/- 1 years; body mass index [BMI]: 28.7 +/- 0.8) and 50 matched ovulatory controls (age: 25.1 +/- 0.7 years; BMI: 28.5 +/- 0.5) was performed. Carotid IMT, brachial FMD, and blood for fasting glucose, insulin, leptin, adiponect…

AdultBlood Glucosemedicine.medical_specialtyinsulinBrachial ArteryendotheliumPeptide Hormonesmedicine.medical_treatmentAdipokineleptinBody Mass IndexInsulin resistanceInternal medicineAdipocytesmedicineBody Fat DistributionHumansResistinObesityProspective Studiescardiovascular diseasesEndothelial dysfunctionAdiponectinadiponectinbusiness.industryInsulinLeptinpcosEndothelial dysfunction in PCOS: role of obesity and adipose hormones.nutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryVasodilationCarotid ArteriesEndocrinologyCase-Control Studiespcos; endothelium; insulin; adiponectin; leptincardiovascular systemCytokinesFemaleResistinEndothelium VascularInsulin ResistanceTunica IntimaTunica MediabusinessBlood Flow VelocityPolycystic Ovary Syndrome
researchProduct